GlucoTrack Inventory Turnover from 2010 to 2025

GCTK Stock  USD 0.35  0.01  1.76%   
GlucoTrack Inventory Turnover yearly trend continues to be quite stable with very little volatility. Inventory Turnover may rise above 0.32 this year. Inventory Turnover is a ratio showing how many times a company's inventory is sold and replaced over a period, indicating the efficiency of inventory management. View All Fundamentals
 
Inventory Turnover  
First Reported
2010-12-31
Previous Quarter
0.19
Current Value
0.32
Quarterly Volatility
0.30278669
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check GlucoTrack financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among GlucoTrack's main balance sheet or income statement drivers, such as Depreciation And Amortization of 12.3 K, Interest Expense of 3.3 K or Selling General Administrative of 2.4 M, as well as many indicators such as Price To Sales Ratio of 53.8 K, Dividend Yield of 0.0 or PTB Ratio of 32.09. GlucoTrack financial statements analysis is a perfect complement when working with GlucoTrack Valuation or Volatility modules.
  
Check out the analysis of GlucoTrack Correlation against competitors.
For more information on how to buy GlucoTrack Stock please use our How to buy in GlucoTrack Stock guide.

Latest GlucoTrack's Inventory Turnover Growth Pattern

Below is the plot of the Inventory Turnover of GlucoTrack over the last few years. It is a ratio showing how many times a company's inventory is sold and replaced over a period, indicating the efficiency of inventory management. GlucoTrack's Inventory Turnover historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in GlucoTrack's overall financial position and show how it may be relating to other accounts over time.
Inventory Turnover10 Years Trend
Slightly volatile
   Inventory Turnover   
       Timeline  

GlucoTrack Inventory Turnover Regression Statistics

Arithmetic Mean0.39
Geometric Mean0.27
Coefficient Of Variation78.22
Mean Deviation0.27
Median0.28
Standard Deviation0.30
Sample Variance0.09
Range0.7467
R-Value(0.69)
Mean Square Error0.05
R-Squared0.48
Significance0
Slope(0.04)
Total Sum of Squares1.38

GlucoTrack Inventory Turnover History

2025 0.32
2024 0.19
2020 0.17
2019 0.28
2018 0.56
2017 0.15
2016 0.042

About GlucoTrack Financial Statements

GlucoTrack investors utilize fundamental indicators, such as Inventory Turnover, to predict how GlucoTrack Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Inventory Turnover 0.19  0.32 

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether GlucoTrack is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if GlucoTrack Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Glucotrack Stock. Highlighted below are key reports to facilitate an investment decision about Glucotrack Stock:
Check out the analysis of GlucoTrack Correlation against competitors.
For more information on how to buy GlucoTrack Stock please use our How to buy in GlucoTrack Stock guide.
You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of GlucoTrack. If investors know GlucoTrack will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about GlucoTrack listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(58.20)
Return On Assets
(2.04)
Return On Equity
(19.43)
The market value of GlucoTrack is measured differently than its book value, which is the value of GlucoTrack that is recorded on the company's balance sheet. Investors also form their own opinion of GlucoTrack's value that differs from its market value or its book value, called intrinsic value, which is GlucoTrack's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because GlucoTrack's market value can be influenced by many factors that don't directly affect GlucoTrack's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between GlucoTrack's value and its price as these two are different measures arrived at by different means. Investors typically determine if GlucoTrack is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, GlucoTrack's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.